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1. INTRODUCTION 
Caldesman is a thin filament-associated protein 
which has been implicated in the regulation of smooth 
muscle contraction 111, The isolated protein is capable 
of interaction in vitro with actin [2], myosin [3], 
tropomyosin [4] and calmodulin [2]. The calmodulin in- 
teraction is Ca’“-dependent and has been suggested to 
bc important in regulating the ability of caldesmon to 
inhibit smooth muscle actin-activated myosin MgATP- 
ase by dissociating caldesmon from actin [S], Chicken 
gizzard cafdestnon, cDNA clones have been sequenced 
in two laboratories [6,7]. The deduced amino acid SC- 
quences probably represent the two isoforms of chicken 
gizzard caldesmon [g]. The dopmain structure of 
caldesmon has been extensively studied [9,10]. The 
myosin-binding domain is located in the N-terminal 
region of caldesmon, whereas the actin-, tropomyosin- 
and calmodulin-binding domains are located near the 
opposite end of the molecule. Calmodulin-binding sites 
have been identified in several known cafmodulin- 
binding proteins and generally consist of - 18 amino 
acids having a basic amphilic u-helical structure [111. 
Examination of the amino acid sequence of calmodulin- 
binding fragments of cafdesmon reveals one such se- 
quence: Arg-593-His-610 [6,12]. However, Bartegi et 
al. [ 131 recently concluded that this does not represent 
the calmodulin-binding site since a 10 kDa peptide cor- 
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responding to the C-terminus of caldesmon (Trp-659- 
Pro-756) binds calmodulin but does not contain this se- 
quence. CNBr peptides corresponding tothe remainder 
of the caldesmon molecule did not bind to immobilized 
calmodulin. We have pursued this surprising conclusion 
by examining the effects of specific hemical modifica- 
tion of His-610 located at the C-terminal end of the 
basic amphiphilic a-helix and conclude that this indeed 
is not the calmodufin-binding site. 
2. MATERIALS AND METHODS 
[y.‘“P]ATI’ (20-40 Ci/mmol) was purchased from Amersham 
(Oakville, Ontario, Canada) and diethylpyrocarbonate and hydrox- 
ylaminc from Sigma (St, Louis, MO), Dithiothreitol was purchased 
from Woehringer Mannhcim (Dorval, Quebec, Canada) and elec- 
trophoresis reagents from Bio.Had (Mississauya, Ontario, Canada). 
Genera! laboratory reagents used were of analytical grade or better 
and were purchased from Fisher Scientific (Calgary, Alberta, 
Canada), Proteins were purified by methods published earlier: 
chicken gizzard caldesmon [Irl], tropomyosin [14] and actin [IS], rab- 
bit skeletal muscle actin 116) and myosin [17], and bovine brain 
calmodulin [18]. Calmodulin and tropomyosin were coupled to 
CNBr-aciivated Sepharose 413 (Pharmacia, Bait d’Urfe, Quebec, 
Canada) according to the manufacturer’s insrructions. 
2.2. CarbeUtoxylutiott of caldcsttton 
The sole imidazole function of caldesmon was carbethoxylated with 
diethylpyrocarbonate using the method described by Miles [IQ). 
Caldesmon (1 .O mg/ml) was incubated at 22°C in 0.1 M sodium 
phosphate buffer (pH 6.0) in the sample and reference cuvettes of a 
Pye Unicam PU8800 UV/visible double-beam spectrophotometer. 
The reaction was initiated by the addition to the sample cell of a if&& 
concentrated solution of diethylpyrocarbonate in ethanol to give a 
final reagent concentration of 50 PM (a 4.4.fold molar excess over 
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Smooth m11rc1c nctin (9 &vl) and untreated or carbcthoxyletcd 
caldcrmons (0,57, l,l4, I .72, 2.26, 2.85, J,31 and 5.75&l) were in. 
cubn~cd for 30 min al 25’C in 30 mM Tris.HCI (pti 7.5), 2 mM 
MgCIz, I mM EGTA, 1 mM dithiothreitol, I mM ATP. Samples (0.2 
ml) were thc?n ccntrKu@cd nt IOOOWxg in a Bcckmnn TLIOO ten. 
trifuge for I Ii nr 2*C in order to sediment F-actin arid bind 
caldcsmon. Pcllcts and supernornnrs were subjcctcd to SDS-PAGE. 
The distribution of raldcsman bcbvecn the pcllcts and supernatants 
war qunntificd by dsnaitometric scnnning of the Coomassis blue- 
stained gels using on LKB model 2202 Ultroscan laser densitometer 
equipped with a Hewlett-Packard model 3390A integrator. The & 
values of nctin for control and cnrbcthoxy-caldcsmons were 
crlculntcd by Scatchnrd analysis of the sedimentation detn. 
ATPasc activities were measured as previously described [2 I ] under 
the following conditions: 25 mM Tris.HCI (pH 7.5), 50 mM KC1, 3.5 
mM MgCh, I mM dithiothrcitol, 0.2 mM EGTA, I mM [y-“P)ATP 
(-9OO0 cprn/nnrol), 3.6brM skeletal ectin, 0.57 PM skeletal myosin, 
in the absence or presence of conlrol or carbelliol;y-cnldesrnon (I ,2 
and Z.OpM), in reaction volumes of 0.3 ml at 30°C. Reactions were 
started by addition of ATP, Samples (SO/rl) of reaction mixtures were 
withdrawn at 0.5.min intervals up to 2.5 min forquantificarion of ‘*Pi 
release (21). Rates of ATP hydrolysis werecalculated by linear regrcs- 
sion analysis of the linear time-course data, 
2.5. Oilier procedures 
Protein concentrations were determined by spectrophotometric 
measurements in a Deckman DU-813 UV/visible spcctrophotomctcr 
using the following extinction coefficients: calmodulin, &$,,, = I .9 
[22]; caldesmon, L$&,= 3,3 [23]; tropomyosin, E%& = 2.9 1241; ac- 
tin, &&,.=6.5 [25]; and myosin, EJ!~,,~, = 5.3 [26]. SDS-PAGE was 
performed in O,l% SDS/lO% acrylamide mini-slab gels to analyse 
column elution profiles, or in full-size 0.1% SDS/7.5-20% 
polyacrylamide gradient slab gels with a 50/, acrylnmide stacking gel 
to analyse catdesmon binding to actin. In each case the Laemmli [27J 
buffer system was used. 
3. RESULTS AND DISCUIjSION 
The time course of carbethoxylation of caldesrnon 
with diethylpyrocarbonate is illustrated in Fig. 1. At the 
plateau, - 1 mol N-carbethoxyhistidine was detected/ 
mol caldesmon. This modification was completely 
reversed by incubation of carbethoxylated caldesmon 
overnight with 0.1 M hydroxylamine at pH 7 and 22’C, 
indicating that modification of lysyl or sulfhydryl 
residues did not occur (data not shown) [19]. The spec- 
tra in Fig. 2A demonstrate very little change in A278,,,~ 
following incubation of caldesmon with diethylpyrocar- 
bonate, indicating that little or no modification of 
TIME (min) 
Fig. I, Chcmic;rl mocliricntian of cnldamon with diclhylpyro- 
uarbtrnats. Caldcrmon WRJ incub:tbxl with clicrhylpyrecarbollnrs Ww 
tlcxeribed in 5cction 2. hr.snrbcthuxyloiion NW follewcd bsr 
uontinuc)us rccordlny of A~.Q,,,,,~ The rtoiehlumctry 0r nroclifi~mian 
WIX cnlrulatcd from the nbrorbance vnlrrca, 
tyrosinc rcsiducs has occurred. The spectra in Fig. 2B it- 
lustrate the time-dependent i crease in AzJ~,,,,, (histidine 
modification) with no significant change in A27Rt~m, in- 
dicative of no chemical modification of ryrosine 
residues. Treatment of caldesmon with a4.4.fold molar 
excess of diethylpyrocarbonate herefore results in 
specific and stoichiomctric modification of the sole 
histidine residue. 
Catbethoxylation of a 1: 1 molar mixture of 
caldcsmon and calmodulin in the presence of Ca*’ 
resulted in the incorporation of 0.92 mol N- 
carbethoxyhistidine/mol protein (Fig. 3), Calmodulin, 
like caldcsmon, contains one histidine residue [28] 
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Fig. 2. Spectral analysis of the carbethoxylation reaction. A. Spectra 
were recorded before (-) and after (-- -) the reaction shown in 
Fig? 1 with reaction buffer in the reference cell of the Pye Unicam 
spectrophotomcter. B. During the course of a reaction identical to 
that shown in Fig. I, spectra were recorded at selected times (10, 15, 
17, 20, 25, 30, 40 and 50 min). The reference cell contained an 
identical mixture except for the omission of diethylpyrocarbonate 
which was replaced by an equal volume of vehicle (ethanol). 
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salmotlulin. 
which can be carbcthoxylatcd in the presence or absence 
of Ca’” [29]. Removal of Ca’* with EGTA, causing the 
dissociation of calmodulin and ealdesmon, did not 
result in any spectroscopic hange. We can conclude 
therefore that His-610 of caldesmon is accessible to 
diethylpyrocarbonate when complcxed with 
calmodulin, suggesting that this residue is not part of 
the calmodulin-binding site. In support of this conclu- 
sion, carbechoxylated caldesmon, like untreated 
caldesmon, bound to a calmodulin-Scpharose affinity 
column in the presence of Ca”+ and was elut,ed with 
EGTA (data not shown). 
The affinities of smooth muscle actin for control and 
carbethoxylated caldesmons were compared using a 
sedimentation assay as described in section 2. The Kd 
for control caldesmon was determined to be 
0.88 x 10” M and for carbethoxylated caldesmon, 
1.29x 10V6 M. Histidine modification therefore caused 
a slight, possibly insignificant, reduction in the affinity 
of caldesmon for actin. Consistent with this observa- 
tion, carbethoxylated caldesmon was as effective as the 
unmodified protein in inhibition of the actin-activated 
MgATPase activity of skeletal myosin (Table I). 
Table I 
Comparison of ihe effects of control and carbethoxylatcd caldesmons 
on the skeletal actin-activated myosin MgATPase 
Caldesmon ATPase rate 
(nmol Pl/min*mg myosin) 
None 6939% 14.7 (n=2) 
Control, 1.2 ,LLM 371,6~tll.l (n=4) 
Control, 2.0 gM 387,8rn 4.7 (n=2) 
Carbethoxylated, 1.2 PM 383,7ri1*5 (n=4) 
Carbethoxylated, 2.0 kM 332,1~11.2 01=2) 
Azaa(--) o,04 
0.02 
0 
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Fig. 4. Uindina of ctirbcrhex~caldesnlon to immabilizcd 
trapumyonin. Cnrbcthuxylatcd ealdcsmon (3 mg; see Fil. 1) WI 
dialyzed va 20 mM Trir-HCI (pl-I 7.9, I 111bl EGTA, 1 r&l 
dithiothrcital and applied, al a flow rate of IO ml/h, to a column 
(1 X ia cm) of fropomyasilr-Spkurese 40, The column was washed 
with the same buffer and bound pratcin wns elutcd with this buCfer 
containing 0.4 M NnCI, Fractions of 2,5 ml were collected. The inrc~ 
Shows SDS-PACE analysis of the unbound material (peak A) and 
bound protein (peak B). The positions of M, markers arc sJ~owo. 
Cacbcthoxylated caldesmon, like the untreated pro- 
tein, was found to bind to a tropomyosin-Sephzrose af- 
finity column at low ionic strength and was eluted with 
a buffer containing 0.4 M NaCl (Fig. 4). The flow- 
through peak from this column contained polypeptides 
of M, 110 and 90 kDa which probably represent pro- 
teolytic fragments of caldesmon (see gel inset of Fig. 4). 
Specific modification of His-610 of caldesmon did 
not affect its interaction with calmodulin suggesting 
that the basic amphiphilic a-helical sequence 
(Arg-59%His-610) does not represent the calmodulin- 
binding site. These results support the conclusion of 
Bartegi et al. [13] that this site is located in a different 
part of the molecule (towards the C-terminus). 
Carbethoxylation of His-610 of caldesmon had little, if 
any, effect on its affinity for actin or ability to inhibit 
the actin-activated MgATPase activity of skeletal mus- 
cle myosin suggesting that this residue does not play an 
important role in the interaction of caldesmon with ac- 
tin. Finally, carbethoxy-saldesmon bound to 
tropomyosin-Sepharose at low ionic strength and could 
be eluted with NaCl, as for the untreated protein [301. 
On the basis of sequence homologies with the 
tropomyosin-binding domains of skeletal muscle 
troponin T, two regions within the caldesmon molecule 
83 
(Glu=rTOB=Lys-565 and Lyti4Xl’l-Arg-Bill) hnvr bm inv 
plieetcd a$ rro9orrryarrin=bindirry regions [31). The 1attcr 
ecquenct: eonrrina Hts-btt) but e8wbcrhoxylarion elenrly 
dtd net prcvenr the binding of caldermon 10 
tragamyosin, Either this rwidrre is nac invnlved in 
tropamyastn binding or ir ptays w reinlively ~ntnor role 
in the interacrion of cnldesmon with trapemyoain, 
K. 1% reclglcnt al R Fellawahip lram M.R.C.C, nnd M.P.W. ir RII 
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